aap Implantate AG (AAQ1) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.052x

Based on the latest financial reports, aap Implantate AG (AAQ1) has a cash flow conversion efficiency ratio of -0.052x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-659.50K ≈ $-771.02K USD) by net assets (€12.63 Million ≈ $14.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

aap Implantate AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how aap Implantate AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of aap Implantate AG for a breakdown of total debt and financial obligations.

aap Implantate AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of aap Implantate AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Vow Green Metals AS OL:VGM	-0.030x
Lakeside Holding Limited Common Stock NASDAQ:LSH	-0.037x
Lincoln Minerals Ltd AU:LML	-0.041x
Arima Communications Corp TW:8101	-0.072x
CS Corporation KQ:065770	-0.030x
TOPBI International Holdings Ltd TW:2929	-0.036x
Quickfee Ltd AU:QFE	-0.564x
Wellchange Holdings Company Limited NASDAQ:WCT	-0.149x

Annual Cash Flow Conversion Efficiency for aap Implantate AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of aap Implantate AG from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see AAQ1 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.46 Million ≈ $12.23 Million	€-1.12 Million ≈ $-1.31 Million	-0.107x	+70.14%
2023-12-31	€8.10 Million ≈ $9.47 Million	€-2.92 Million ≈ $-3.41 Million	-0.360x	-143.82%
2022-12-31	€12.83 Million ≈ $15.00 Million	€-1.89 Million ≈ $-2.21 Million	-0.148x	+23.67%
2021-12-31	€12.78 Million ≈ $14.94 Million	€-2.47 Million ≈ $-2.89 Million	-0.193x	+45.86%
2020-12-31	€10.29 Million ≈ $12.03 Million	€-3.67 Million ≈ $-4.30 Million	-0.357x	-16.83%
2019-12-31	€18.87 Million ≈ $22.06 Million	€-5.77 Million ≈ $-6.74 Million	-0.306x	-80.31%
2018-12-31	€34.92 Million ≈ $40.82 Million	€-5.92 Million ≈ $-6.92 Million	-0.170x	-32.90%
2017-12-31	€42.56 Million ≈ $49.76 Million	€-5.43 Million ≈ $-6.35 Million	-0.128x	+3.01%
2016-12-31	€54.78 Million ≈ $64.04 Million	€-7.20 Million ≈ $-8.42 Million	-0.131x	--

About aap Implantate AG

F:AAQ1 Germany Medical Devices

Market Cap

$33.72 Million

€28.85 Million EUR

Market Cap Rank

#24980 Global

#2155 in Germany

Share Price

€1.96

Change (1 day)

-2.97%

52-Week Range

€1.13 - €2.22

All Time High

€21.70